Sep 29 2022 |
Wined and Fined: OFSI Imposes Financial Penalty on UK Company for Publicising Sanctioned Crimean Winery |
Greenberg Traurig, LLP |
Sep 29 2022 |
QR Code and Text Messaging Alone Are Insufficient to Disclose Bioengineered Food Ingredients |
K&L Gates LLP |
Sep 29 2022 |
FDA Proposes Updated Definition for “Healthy” Claim |
Keller and Heckman LLP |
Sep 29 2022 |
California Federal Court Substantially Upholds Bioengineered Food Disclosure But Remands QR Code and Text Message Disclosure Options to USDA for Further Rulemaking |
ArentFox Schiff LLP |
Sep 29 2022 |
MintzRx — Medicaid Best Price Value Based Purchasing Rules Took Effect July 1, 2022 |
Mintz |
Sep 29 2022 |
MintzRx — Pressure to Combat High Drug Prices Lands PBMs in the Hot Seat |
Mintz |
Sep 29 2022 |
MintzRx — Drug Pricing Update: The Inflation Reduction Act |
Mintz |
Sep 28 2022 |
4th Quarter 2022 Quick Hits for Plan Sponsors and Administrators |
Jackson Lewis P.C. |
Sep 28 2022 |
Tension Over Copay Assistance and Maximizer Programs Continues |
Mintz |
Sep 28 2022 |
MintzRx — Summer 2022 Enforcement Round-Up: Key Trends in Pharmacy Enforcement Actions |
Mintz |
Sep 28 2022 |
MintzRx — Digital Health Update: Federal Government Shows Growing Enforcement Interest in Online Prescribing of Controlled Substances |
Mintz |
Sep 28 2022 |
California Enacts Legal Protections for Cannabis Insurance Providers |
Wilson Elser Moskowitz Edelman & Dicker LLP |
Sep 28 2022 |
Mere Puffery vs False Advertising: Recent Trends |
ArentFox Schiff LLP |
Sep 28 2022 |
Developers Take Note: FDA Issues Clinical Decision Support Software Final Guidance |
Foley & Lardner LLP |
Sep 28 2022 |
New Report Outlines FDA’s Strategy to Ensure the Safety of Imported Produce |
Keller and Heckman LLP |
Sep 27 2022 |
DOJ Announces $900 Million Settlement Tied to Speaker Bureau Payments to Physicians |
Robinson & Cole LLP |
Sep 27 2022 |
FDA Is Accepting EUA Requests for Monkeypox Tests, But Time is of the Essence |
Mintz |
Sep 27 2022 |
Health Foods in China: New Rules Approving Functional Claims |
Keller and Heckman LLP |
Sep 27 2022 |
Last Call: Deadline for Requesting Alabama Medical Cannabis Applications Looms |
Bradley Arant Boult Cummings LLP |
Sep 27 2022 |
FDA Releases Food Safety Prevention Strategies |
Keller and Heckman LLP |
Sep 26 2022 |
Biogen Inc. Agrees to Pay $900 Million to Settle Allegations Related to Improper Physician Payments |
The U.S. Department of Justice |
Sep 26 2022 |
Issue-Spotting Hospital Activities that May Trigger FDA Regulatory Oversight [PODCAST] |
K&L Gates LLP |
Sep 26 2022 |
Federal Appeals Court Upholds USDA Decision Not to Ban “Organic” Label for Hydroponics |
Keller and Heckman LLP |
Sep 24 2022 |
413 Pounds of Concealed Marijuana Intercepted by Cincinnati CBP |
U.S. Customs and Border Protection |
Sep 23 2022 |
Ongoing Foodborne Illness Outbreaks Increasing |
Keller and Heckman LLP |
Sep 22 2022 |
USDA Issues Regulatory Status Response re GM Tomatoes |
Keller and Heckman LLP |
Sep 22 2022 |
Prop 65 Regulatory Update for the Cannabis Industry: Tailored Warnings Become Effective October 1, 2022 with a 1-Year Grace Period for Compliance |
Squire Patton Boggs (US) LLP |
Sep 22 2022 |
China Publishes Draft Standards for Food Additives |
Keller and Heckman LLP |
Sep 21 2022 |
In One Day, California Governor Signs Into Law Ten Cannabis Bills, Including Authorization for Interstate Commerce |
Sheppard, Mullin, Richter & Hampton LLP |
Sep 21 2022 |
FDA Publishes Internal Evaluation of Infant Formula Response |
Keller and Heckman LLP |
Sep 20 2022 |
Pharmaceutical Manufacturer Pays $7.9 Million to Resolve Allegations that it Caused the Submission of Over-the-Counter Drugs to Medicare Part D |
Mintz |
Sep 20 2022 |
Biden's Executive Order Focusing on Biotechnology Offers Opportunities for AgTech Industry |
ArentFox Schiff LLP |
Sep 20 2022 |
“Made with Real Butter” Claim Challenged |
Keller and Heckman LLP |
Sep 20 2022 |
California Enacts Law Prohibiting Employment Discrimination Based On Off-Duty Marijuana Use, Effective 2024 |
Jackson Lewis P.C. |
Sep 19 2022 |
New California Bill Protects Employees’ Off-Duty Marijuana Use |
Foley & Lardner LLP |